title: Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.
abstract: The majority of the p53 genes derived from human colorectal carcinomas contain point mutations. A significant number of these mutations occur in or around amino acids 143, 175, 273, or 281. Experiments presented here demonstrate for the first time that p53 DNA clones containing any one of these mutations cooperate with the activated ras oncogene to transform primary rat embryo cells in culture. These transformed cells produce elevated levels of the human p53 protein, which has extended half-lives (1.5-7 h), as compared to the wild-type human p53 protein (20-30 min). The p53 mutant with an alteration at residue 175 (p53-175H) binds tightly to the cellular heat shock protein, hsc70. In contrast, the p53 mutants possessing mutations at either residue 273 or 281 (p53-273H/281G) do not bind detectably to this heat shock protein and generally are less efficient at forming transformed foci in culture. The transformed cell lines are tumorigenic in nude mice. Thus, two classes of p53 mutant proteins can be distinguished: p53-175H, which cooperates with ras efficiently and binds to hsc70, and p53-273H/281G, which has a reduced efficiency of transformed foci formation and does not bind hsc70. This demonstrates that complex formation between mutant p53 and hsc70 is not required for p53-mediated transformation, but rather it facilitates this function, perhaps by ensuring sequestration of the endogenous wild-type p53 protein. The positive effect on cell proliferation by these mutant p53 proteins is consistent with a role for activated p53 mutants in the genesis of colorectal carcinomas.
authors.affiliation: Department of Molecular Biology, Lewis Thomas Laboratory, Princeton University, New Jersey 08544-1014.
authors.forename: P W
authors.initials: PW
authors.lastname: Hinds
authors.forename: C A
authors.initials: CA
authors.lastname: Finlay
authors.forename: R S
authors.initials: RS
authors.lastname: Quartin
authors.forename: S J
authors.initials: SJ
authors.lastname: Baker
authors.forename: E R
authors.initials: ER
authors.lastname: Fearon
authors.forename: B
authors.initials: B
authors.lastname: Vogelstein
authors.forename: A J
authors.initials: AJ
authors.lastname: Levine
mesh_terms: D000818:Animals; D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D002478:Cells, Cultured; D003001:Cloning, Molecular; D003110:Colonic Neoplasms / Q000235:genetics*; D006207:Half-Life; D006360:Heat-Shock Proteins / Q000378:metabolism; D006801:Humans; D046911:Macromolecular Substances; D051379:Mice; D008819:Mice, Nude; D008970:Molecular Weight; D009154:Mutation; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D051381:Rats; D013329:Structure-Activity Relationship; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism / Q000502:physiology*
chemical_list: D006360:Heat-Shock Proteins; D046911:Macromolecular Substances; D016159:Tumor Suppressor Protein p53; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)